FDA
-
-
-
-
-
-
-
SeaStar Medical to Report First Quarter Financial Results on May 13, 2026
-
-
-
-
-
-
-
SeaStar Medical publishes pediatric kidney injury therapy data
-
-
-
-
-
-
-
SeaStar Medical Announces 1-for-10 Reverse Split
-
-
-
-
-
-
-
SeaStar Medical to Report Third Quarter Financial Results on November 13, 2025
-
-
-
-
-
-
-
SeaStar Medical to Participate in the HC Wainwright 27th Annual Global Investment Conference
-
-
-
-
-
-
-
SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
-
-
-
-
-
-
SeaStar Medical Expands QUELIMMUNE Adoption for Critically Ill Pediatric Patients with Acute Kidney Injury (AKI)
-
326,554 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

